Results 21 to 30 of about 44,306 (276)

Successful Treatment with Topical Diphenylcyclopropenone for Three Cases of Anogenital Warts in Children [PDF]

open access: yesCase Reports in Dermatology, 2019
Anogenital warts are caused by human papillomavirus types 6 and 11. They are rare in children, and treatment is difficult since conventional treatments are generally painful and require the patient to be anesthetized. Topical diphenylcyclopropenone (DPCP)
Kazunori Miyata   +3 more
doaj   +2 more sources

Sustained Decline in Hospitalisations for Anogenital Warts in Australia: Analysis of National Hospital Morbidity Data 2003–2020 [PDF]

open access: yesTropical Medicine and Infectious Disease
In Australia, school-based human papillomavirus (HPV) vaccination was introduced initially for girls in 2007, and then also for boys in 2013. While studies have shown declines in the incidence of anogenital warts, there is a paucity of recent data ...
Harunor Rashid   +3 more
doaj   +2 more sources

Combination of qualitative and quantitative methods for developing a new Health Related Quality of Life measure for patients with anogenital warts [PDF]

open access: yesHealth and Quality of Life Outcomes, 2005
Background Anogenital warts are the most easily recognized sign of genital Human Papilloma Virus infection. The objective was to develop a short, valid and reliable questionnaire to measure Health Related Quality of Life (HRQL) in patients with ...
Olmos Luis   +7 more
doaj   +2 more sources

Position statement for the diagnosis and management of anogenital warts. [PDF]

open access: yesJ Eur Acad Dermatol Venereol, 2019
Anogenital warts (AGW) can cause economic burden on healthcare systems and are associated with emotional, psychological and physical issues.
O'Mahony C   +12 more
europepmc   +2 more sources

Success of Intralesional Purified Protein Derivative Immunotherapy in the Treatment of Anogenital Warts: A Case Report. [PDF]

open access: goldJ Exp Pharmacol, 2022
Achdiat PA   +7 more
europepmc   +3 more sources

Demographic characteristics and risk factors in Turkish patients with anogenital warts

open access: greenJournal of Infection and Public Health, 2016
Summary: Anogenital warts (AGW) are one of the most common sexually transmitted diseases worldwide. The determination of groups vulnerable to contracting anogenital warts (AGW) leads to the development of policies for disease control and of prevention ...
Emine Tamer   +3 more
doaj   +2 more sources

Genotype distribution of human papillomavirus in anogenital warts of male patients in Taiwan

open access: hybridDermatologica Sinica, 2012
Background: Reports on the prevalence of different human papillomavirus (HPV) genotypes in male patients with anogenital HPV infection are limited. Methods: We retrospectively analyzed the HPV genotypes of 100 consecutive patients seen in our department ...
Yu-Pin Cheng   +3 more
doaj   +2 more sources

A Multicentre, Randomised Clinical Trial to Compare a Topical Nitrizinc® Complex Solution Versus Cryotherapy for the Treatment of Anogenital Warts. [PDF]

open access: yesDermatol Ther (Heidelb), 2020
Anogenital warts (AGW) are a relevant clinical issue in the field of sexually transmitted disease, and to date no treatment provides a satisfactory clearance rate. Treatment can be both medical and surgical, and be provided by a healthcare provider or by
Pontini P   +7 more
europepmc   +2 more sources

Aspects of Langerhans cells and TNF-α in the cutaneous immunity of anogenital warts. [PDF]

open access: yesAn Bras Dermatol, 2020
Background Anogenital warts are the leading sexually transmitted infection in patients seeking care at specialized clinics. They may display a vast array of forms, according to the interaction of the virus with the host's immunity.
Veasey JV, Campaner AB, Lellis RF.
europepmc   +2 more sources

Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.

open access: yesHealth Technol Assess, 2020
BACKGROUND The comparative efficacy, and cost-effectiveness, of imiquimod or podophyllotoxin cream, either alone or in combination with the quadrivalent HPV vaccine (Gardasil®, Merck Sharp & Dohme Corp., Merck & Co., Inc., Whitehouse Station, NJ, USA) in
Gilson R   +14 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy